On Target Laboratories develops technologies which enable surgeons to remove more cancer during surgery. Since On Target’s founding in 2010, our team of researchers and scientists has been devoted to empowering surgeons with the tools they need to detect more cancer that otherwise may have been left behind with the current standard of care.

On Target Laboratories’ technology is based on the pioneering work of Dr. Philip Low. Dr. Low is a Ralph Corley Distinguished Professor of Chemistry at Purdue University and the Director of the Purdue University Center for Drug Discovery. After discovering an innovative intraoperative fluorescent imaging agent, Dr. Low and his team at Purdue University researched the use of this imaging agent to make cancer more visible in the operating room.